Metoprolol tartrate is a medication used to treat hypertension, or high blood pressure. In order to avoid heart attacks, cardiac strokes, and renal issues, it helps to lower excessive blood pressure. In order to increase the likelihood of surviving a heart attack, metoprolol tartrate is also used to treat angina, popularly known as chest discomfort. Metoprolol tartrate is a member of the beta-blocker medication class, which prevents the heart and blood vessels from being damaged by certain natural substances like epinephrine.
The market for metoprolol tartrate is predicted to reach US$ 6,101.4 Mn in value in 2022 and grow at a CAGR of 3.3% during the forecast period (2022-2030).
To Get More Business Strategies Sample Copy of Report @ https://www.coherentmarketinsights.com/insight/request-sample/5256
Metoprolol tartrate, a beta blocker, is anticipated to be used more often as a result of the rising prevalence of hypertension, fueling market expansion throughout the forecast period. For instance, according to data released by the Centers for Disease Control and Prevention (CDC) on September 27, 2021, approximately 116 million adults in the United States, or about half of the adult population, had hypertension in 2019. This condition is indicated by a systolic blood pressure that is greater than 130 mmHg or by taking medication to treat it.
Over the course of the forecast period, industry participants are anticipated to launch more products, fueling the expansion of the worldwide metoprolol tartrate market. It is a standard quantity of drug substance or ingredient in form of 37.5 mg tablets and 75 mg tablets. As there are already 25 mg, 50 mg, and 100 mg strengths of Metoprolol Tartrate Tablets USP, these new strengths of 37.5 mg and 75 mg tablets will be a fresh entry on the market for Metoprolol Tartrate.
Due to research and development of metoprolol tartrate for the treatment of cardiological problems associated with COVID-19 patients, the COVID-19 pandemic is anticipated to propel the growth of the worldwide metoprolol tartrate market. For instance, on September 7, 2021, an article about the effects of metoprolol on COVID-19 patients at a pilot study was published in the Science Direct journal, a database of references and abstracts of life science research. This study found that intravenous metoprolol administration to patients with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) was safe, reduced exacerbation of lung inflammation, and improved oxygenation. Metoprolol repurposing for COVID-19-related ARDS proved to be a secure and affordable method that can lessen the effects of the COVID-19 pandemic.
Over the projected period, metoprolol tartrate product recalls might have a negative impact on the global market. For instance, on September 9, 2020, Aurobindo Pharma USA Inc., a pharmaceutical manufacturing company, announced the voluntary recall of a single lot of 2820 packaging bottles containing metoprolol tartrate tablets. This action was taken in response to reports that a metal wire had been discovered in a tablet. On September 20, 2021, the Food and Drug Administration (FDA) of the United States classified the recall as Class II.
The market for metoprolol tartrate is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa based on geography.
Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/5256
Due to the rising frequency of cardiovascular disorders, North America is anticipated to be the most dominating region over the projection period. For instance, the Division for Heart Disease and Stroke Prevention, a division of the Centers for Disease Control and Prevention, published a fact sheet on the prevalence of hypertension in the United States on March 22, 2021. The fact sheet stated that in 2019, approximately 47.3% of the adult population, or about 116 million people, suffered from hypertension, with approximately 91.7 million of those people receiving medication treatment.
Pharma India Limited, Aurobindo Pharma USA, AstraZeneca, Sandoz Canada Inc., Novartis Pharmaceuticals Canada Inc., Apotex Inc., Alembic Pharmaceuticals Limited, Ipca Laboratories Ltd., Pharmaceuticals LLC, Rubicon Resear, Hikma Pharmaceuticals PLC, Mylan N.V., CTX Life Sciences Pvt. Ltd., Dr. Reddy’s Laboratories Ltd., Validus and Sun Pharmaceutical Industries Inc.
Reasons to buy this Metoprolol Tartrate Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ Metoprolol Tartrate market size estimation and recent advancements in the industry are explained.
Purchase This Premium Report With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/5256
The Study Objectives are:
✔ A comprehensive insight into key players operating in the Metoprolol Tartrate Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Metoprolol Tartrate Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Metoprolol Tartrate Industry Impact
Chapter 2 Global Metoprolol Tartrate Competition by Types, Applications, and Top Regions and Countries
2.1 Global Metoprolol Tartrate (Volume and Value) by Type
2.3 Global Metoprolol Tartrate (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Metoprolol Tartrate Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Metoprolol Tartrate Market Analysis
Chapter 6 East Asia Metoprolol Tartrate Market Analysis
Chapter 7 Europe Metoprolol Tartrate Market Analysis
Chapter 8 South Asia Metoprolol Tartrate Market Analysis
Chapter 9 Southeast Asia Metoprolol Tartrate Market Analysis
Chapter 10 Middle East Metoprolol Tartrate Market Analysis
Chapter 11 Africa Metoprolol Tartrate Market Analysis
Chapter 12 Oceania Metoprolol Tartrate Market Analysis
Chapter 13 South America Metoprolol Tartrate Market Analysis
Chapter 14 Company Profiles and Key Figures in Metoprolol Tartrate Business
Chapter 15 Global Metoprolol Tartrate Market Forecast (2022-2028)
Chapter 16 Conclusions
Customization of the Report
Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.
Browse Press Release Here: https://www.coherentmarketinsights.com/press-release/metoprolol-tartrate-market-4551
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027